PUBLICATIONS

Clinical Research Focus. 13th Edition February Marks the Beginning of Mandatory Use of CTIS for EMA’s New Clinical Trial Applications The use of the Clinical Trials Information System (CTIS) has become mandatory for new clinical trial applications and now serves as the single-entry point for submission and regulatory assessment. The new regulation has come into effect on January 31, 2023. EMA informed its Management Read more

Clinical Research Focus. 12th Edition Cromos Pharma’s Guide to the EU Legal Representation Requirements Any biopharmaceutical company that plans to conduct clinical trials in the EU and doesn’t have a registered office in the European Economic Area (EEA), needs to use the services of a Legal Representative. First established in 2001, this provision aims to ensure that the EU offers Read more

Clinical Research Focus. 11th Edition Serbia – The Land of Opportunity in Clinical Research Over the years, Serbia has become a highly reputable location to conduct clinical research. The country has actively strived towards developing a robust healthcare system and adopted full GCP compliance. There are 322 clinical trials currently occurring inside Serbia’s borders. Increasing number of biotechnology and pharmaceutical Read more

Serbia is a land of opportunity for clinical research The past, the present, and the future When someone mentions Serbia in a scientific context, the name of Nicola Tesla inevitably comes to mind. But very few people know that Serbia has produced some of the truly great minds in medicine. One such scientist is Miodrag Radulovacki, who is considered to be the father of Read more